Savient Pharmaceuticals (SVNT) Posts Q2 Loss of 23c/Share
Tweet Send to a FriendGet Alerts SVNT Hot Sheet
Price: $0.57 +1.79%
Revenue Growth %: +34.3%
Financial Fact:
Research and development: 6.13M
Today's EPS Names:
MGT, RXN, KID, More
Revenue Growth %: +34.3%
Financial Fact:
Research and development: 6.13M
Today's EPS Names:
MGT, RXN, KID, More
Trade SVNT Now!
Savient Pharmaceuticals (NASDAQ: SVNT) reported Q2 EPS of ($0.23), $0.21 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $4.6 million versus the consensus estimate of $5.24 million.
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Savient Pharmaceuticals (SVNT) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
- Campbell Soup Co. (CPB) Tops Q3 EPS by 6c; Boosts FY13 Outlook
- JA Solar Holdings (JASO) Posts Q1 Loss of 85c/ADS; Guides Shipments
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
